Viewing Study NCT03521934


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2025-12-26 @ 1:06 AM
Study NCT ID: NCT03521934
Status: TERMINATED
Last Update Posted: 2022-10-28
First Post: 2018-04-30
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Sponsor: Lexicon Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-06-15
Start Date Type: ACTUAL
Primary Completion Date: 2020-06-05
Primary Completion Date Type: ACTUAL
Completion Date: 2020-06-05
Completion Date Type: ACTUAL
First Submit Date: 2018-04-30
First Submit QC Date: None
Study First Post Date: 2018-05-11
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-09-30
Results First Submit QC Date: None
Results First Post Date: 2022-10-28
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2020-10-28
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2022-09-30
Last Update Post Date: 2022-10-28
Last Update Post Date Type: ACTUAL